[en] EGR1 is an immediate early gene with a wide range of activities as transcription factor, spanning from regulation of cell growth to differentiation. Numerous studies show that EGR1 either promotes the proliferation of stimulated cells or suppresses the tumorigenic growth of transformed cells. Upon interaction with ARF, EGR1 is sumoylated and acquires the ability to bind to specific targets such as PTEN and in turn to regulate cell growth. ARF is mainly localized to the periphery of nucleolus where is able to negatively regulate ribosome biogenesis. Since EGR1 colocalizes with ARF under IGF-1 stimulation we asked the question of whether EGR1 also relocate to the nucleolus to interact with ARF. Here we show that EGR1 colocalizes with nucleolar markers such as fibrillarin and B23 in the presence of ARF. Western analysis of nucleolar extracts from HeLa cells was used to confirm the presence of EGR1 in the nucleolus mainly as the 100 kDa sumoylated form.
We also show that the level of the ribosomal RNA precursor 47S is inversely correlated to the level of EGR1 transcripts. The EGR1 iseffective to regulate the synthesis of the 47S rRNA precursor. Then we demonstrated that EGR1 binds to the Upstream Binding Factor (UBF) leading us to hypothesize that the regulating activity of EGR1 is mediated by its interaction within the transcriptional complex of RNA polymerase I. These results confirm the presence of EGR1 in the nucleolus and point to a role for EGR1 in the control of nucleolar metabolism.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Ponti, Donatella
Bellenchi, Gian Carlo
Puca, Rosa
Bastianelli, Daniela
Maroder, Marella
Ragona, Giuseppe
Roussel, Pascal
Thiry, Marc ; Université de Liège - ULiège > Département des sciences de la vie > Biologie cellulaire
Mercola, Dan
Calogero, Antollena
Language :
English
Title :
The Transcription Factor EGR1 Localizes to the Nucleolus and Is Linked to Suppression of Ribosomal Precursor Synthesis
Publication date :
01 May 2014
Journal title :
PLoS ONE
eISSN :
1932-6203
Publisher :
Public Library of Science, San Franscisco, United States - California
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Bernstein SH, Kharbanda SM, Sherman ML, Sukhatme VP, Kufe DW (1991) Posttranscriptional regulation of the zinc finger-encoding EGR-1 gene by granulocyte-macrophage colony-stimulating factor in human U-937 monocytic leukemia cells: involvement of a pertussis toxin-sensitive G protein. Cell Growth Differ 2: 273-278.
Sukhatme VP, Cao XM, Chang LC, Tsai-Morris CH, Stamenkovich D, et al. (1988) A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53: 37-43.
Baron V, Adamson ED, Calogero A, Ragona G, Mercola D (2006) The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther 13: 115-124. (Pubitemid 43113412)
Zwang Y, Sas-Chen A, Drier Y, Shay T, Avraham R, et al. (2011) Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals. Mol Cell 42: 524-535.
Krones-Herzig A, Mittal S, Yule K, Liang H, English C, et al. (2005) Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Research 65: 5133-5143. (Pubitemid 40827322)
Virolle T, Adamson ED, Baron V, Birle D, Mercola D, et al. (2001) The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol 3: 1124-1128. (Pubitemid 33130464)
de Belle I, Huang RP, Fan Y, Liu C, Mercola D, et al. (1999) p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene 18: 3633-3642. (Pubitemid 29322388)
Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, et al. (1995) Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene 11: 1261-1269.
Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, et al. (1997) Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72: 102-109. (Pubitemid 27314646)
Liu C, Yao J, de Belle I, Huang RP, Adamson E, et al. (1999) The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem 274: 4400-4411.
Calogero A, Lombari V, De Gregorio G, Porcellini A, Ucci S, et al. (2004) Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma. Cancer Cell Int 4: 1.
Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, et al. (2001) The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res 7: 2788-2796. (Pubitemid 32911386)
Huang RP, Liu C, Fan Y, Mercola D, Adamson ED (1995) Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Research 55: 5054-5062.
Liu C, Calogero A, Ragona G, Adamson E, Mercola D (1996) EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity. Crit Rev Oncog 7: 101-125.
Calogero A, Porcellini A, Lombari V, Fabbiano C, Arcella A, et al. (2011) Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression. Cancer Cell Int 11: 5.
Montanaro L, Trere D, Derenzini M (2008) Nucleolus, ribosomes, and cancer. Am J Path 173: 301-310.
Ruggero D (2012) Revisiting the nucleolus: from marker to dynamic integrator of cancer signaling. Sci Signal 5: pe38.
Brina D, Grosso S, Miluzio A, Biffo S (2011) Translational control by 80S formation and 60S availability: the central role of eIF6, a rate limiting factor in cell cycle progression and tumorigenesis. Cell Cycle 10: 3441-3446.
Belin S, Beghin A, Solano-Gonzalez E, Bezin L, Brunet-Manquat S, et al. (2009) Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PloS One 4: e7147.
Drygin D, Rice WG, Grummt I (2010) The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu Rev Pharmacol Toxicol 50: 131-156.
Bernstein KA, Bleichert F, Bean JM, Cross FR, Baserga SJ (2007) Ribosome biogenesis is sensed at the Start cell cycle checkpoint. Mol Biol Cell 18: 953-964. (Pubitemid 46402877)
Di Cristofano A, Pandolfi PP (2000) The multiple roles of PTEN in tumor suppression. Cell 100: 387-390.
Boone DN, Qi Y, Li Z, Hann SR (2011) Egr1 mediates p53-independent c-Myc-induced apoptosis via a non-canonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci USA 108: 632-637.
Ayrault O, Andrique L, Fauvin D, Eymin B, Gazzeri S, et al. (2006) Humn tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorilation. Oncogene 25: 7577-7580.
Karayan L, Riou JF, Seite P, Migeon J, Cantereau A, et al. (2001) Human ARF protein interacts with topoisomerase I and stimulates its activity. Oncogene 20: 836-848. (Pubitemid 32198177)
Xirodimas DP, Chisholm J, Desterro JM, Lane DP, Hay RT (2002) P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS lett 528: 207-211. (Pubitemid 35258025)
Yu J, Zhang SS, Saito K, Williams S, Arimura Y, et al. (2009) PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J 28: 21-33.
Backman S, Stambolic V, Mak T (2002) PTEN function in mammalian cell size regulation. Curr Opin Neurobiol 12: 516-522. (Pubitemid 35284086)
Vogt PK (2001) PI 3-kinase, mTOR, protein synthesis and cancer. Trends Mol Med 7: 482-484.
Roth J, Bendayan M, Carlemalm E, Villiger W, Garavito M (1981) Enhancement of structural preservation and immunocytochemical staining in low temperature embedded pancreatic tissue. J Histochem Cytochem 29: 663-671. (Pubitemid 11090711)
Ochs R, Lischwe M, O'Leary P, Busch H (1983) Localization of nucleolar phosphoproteins B23 and C23 during mitosis. Exp Cell Res 146: 139-149.
Sirri V, Roussel P, Hernandez-Verdun D (2000) In vivo release of mitotic silencing of ribosomal gene transcription does not give rise to precursor ribosomal RNA processing. J Cell Biol 148: 259-270. (Pubitemid 30078238)
Font J, Mackay JP (2010) Beyond DNA: zinc finger domains as RNA-binding modules. Methods Mol Biol 649: 479-491.
Karni-Schmidt O, Friedler A, Zupnick A, McKinney K, Mattia M, et al. (2007) Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene 26: 3878-3891. (Pubitemid 46878137)
Yu J, de Belle I, Liang H, Adamson ED (2004) Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol Cell 15: 83-94. (Pubitemid 38850221)
Sugimoto M, Kuo ML, Roussel MF, Sherr CJ (2003) Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 11: 415-424. (Pubitemid 36293835)
Apicelli AJ, Maggi LB Jr, Hirbe AC, Miceli AP, Olanich ME, et al. (2008) A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function. Mol Cell Biol 28: 1068-1080. (Pubitemid 351160063)
Voit R, Grummt (2001) Phosphorylation of UBF at serine 388 is required for interaction with RNA polymerase I and activation of rDNA transcription. Proc Natl Acad Sci U S A 98: 13631-13636.
O'Sullivan AC, Sullivan GJ, McStay B (2002) UBF binding in vivo is not restricted to regulatory sequences within the vertebrate ribosomal DNA repeat. Mol Cell Biol 22: 657-668. (Pubitemid 34027509)
Ciarmatori S, Scott PH, Sutcliffe JE, McLees A, Alzuherri HM, et al. (2001) Overlapping functions of the pRb family in the regulation of rRNA synthesis. Mol Cell Biol 21: 5806-5814. (Pubitemid 32737798)
Zhai W, Comai L (2000) Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol Cell Biol 20: 5930-5938. (Pubitemid 30613042)
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
